Symbols

Symbols

XBIT

XBIT News

Newswire

09:13

John Simard to retire as CEO of XBiotech, biopharmaceutical company focused on developing True Human monoclonal antibodies.

06:20

Retail Investors Hold Majority Stake in XBiotech Inc. (NASDAQ:XBIT), with 52% Ownership

18:12

XBiotech Inc. shares rise 1.59% after-hours despite reporting a Q2 loss of $1.8 million.

14:19

3 Penny Stocks to Watch with Market Caps Above $90M

19:16

Quest PharmaTech Opposes OQPBIOM's Acquisition of AdBioTech Amidst Uninformed Acquisition Strategy.

About XBIT

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction